Cargando…
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
OBJECTIVES: The aims of this study were to update the evidence on the incidence and prevalence rates of vaccine preventable infections (VPI) in patients with autoimmune inflammatory rheumatic diseases (AIIRD) and compare the data to the general population when available. METHODS: A literature search...
Autores principales: | Furer, Victoria, Rondaan, Christien, Heijstek, Marloes, van Assen, Sander, Bijl, Marc, Agmon-Levin, Nancy, Breedveld, Ferdinand C, D'Amelio, Raffaele, Dougados, Maxime, Kapetanovic, Meliha Crnkic, van Laar, Jacob M, Ladefoged de Thurah, Annette, Landewé, Robert, Molto, Anna, Müller-Ladner, Ulf, Schreiber, Karen, Smolar, Leo, Walker, Jim, Warnatz, Klaus, Wulffraat, Nico M, Elkayam, Ori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803008/ https://www.ncbi.nlm.nih.gov/pubmed/31673420 http://dx.doi.org/10.1136/rmdopen-2019-001041 |
Ejemplares similares
-
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
por: Rondaan, Christien, et al.
Publicado: (2019) -
Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations
por: Jansen, Marc H., et al.
Publicado: (2022) -
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
por: Furer, Victoria, et al.
Publicado: (2021) -
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
por: Laster, Andrew J, et al.
Publicado: (2022) -
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study
por: Gazitt, Tal, et al.
Publicado: (2023)